VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Saturday, January 10, 2026
Stock Comparison
AstraZeneca PLC vs The Italian Sea Group S.p.A.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisThe Italian Sea Group S.p.A.
TISG · Euronext Milan (Borsa Italiana)
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into The Italian Sea Group S.p.A.'s moat claims, evidence, and risks.
View TISG analysisComparison highlights
- Moat score gap: AstraZeneca PLC leads (71 / 100 vs 61 / 100 for The Italian Sea Group S.p.A.).
- Segment focus: AstraZeneca PLC has 6 segments (41% in Oncology); The Italian Sea Group S.p.A. has 2 segments (89.7% in Shipbuilding).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: AstraZeneca PLC has 4 moat types across 3 domains; The Italian Sea Group S.p.A. has 5 across 3.
Primary market context
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
The Italian Sea Group S.p.A.
Shipbuilding
Luxury yacht and superyacht shipbuilding (motor and sailing, 24m+ projects under construction/contract)
Global
Ultra-high-net-worth individuals (owners) and yacht brokers; occasional fleet/charter buyers
Designer/shipyard (OEM) and brand owner
89.7%
Side-by-side metrics
Moat coverage
Shared moat types
AstraZeneca PLC strengths
The Italian Sea Group S.p.A. strengths
Segment mix
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
The Italian Sea Group S.p.A. segments
Full profile >Shipbuilding
Oligopoly
Refit
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.